Turning Point Benefit Group’s Elanco Animal Health ELAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
– Sell
-18
Closed -$407 – 309
2025
Q4
$407 Hold
18
– – ﹤0.01% 670
2025
Q3
$374 Buy
+18
New +$302 ﹤0.01% 548

Other funds holding ELAN

Turning Point Benefit Group's ELAN Position: Q1 2026 in Review

Turning Point Benefit Group sold out of Elanco Animal Health (ELAN) in Q1 2026, closing a stake of 18 shares — an estimated $407 sold.

Turning Point Benefit Group first reported a position in ELAN in Q3 2025 and held it in 2 quarters. The position peaked at $407 in Q4 2025. 519 funds tracked by Wall St. Rank hold ELAN as of Q1 2026.

  • Turning Point Benefit Group reported no remaining Elanco Animal Health position as of Q1 2026 after selling out during the quarter.
  • Turning Point Benefit Group sold 18 Elanco Animal Health shares in Q1 2026, an estimated $407.
  • Turning Point Benefit Group first reported a position in Elanco Animal Health in Q3 2025 and held it in 2 quarters.
  • Turning Point Benefit Group's Elanco Animal Health position peaked at $407 in Q4 2025.
  • 519 funds tracked by Wall St. Rank held Elanco Animal Health as of Q1 2026.

Based on Turning Point Benefit Group's 13F filing for Q1 2026, filed 12 May 2026.